Chemotherapy- and Irradiation-Induced Bone Loss in Adults with Solid Tumors

por Wissing, Michel D.
Publicado 2015

Chronic prednisone, metformin, and nonsteroidal anti-inflammatory drug use and clinical outcome in a cohort of bladder cancer patients undergoing radical cystectomy in Québec, Cana...

por Wissing, Michel D., O’Flaherty, Ana, Dragomir, Alice, Tanguay, Simon, Kassouf, Wassim, Aprikian, Armen G.
Publicado 2023

Safety and Efficacy of 2D Brachytherapy vs. 3D Image-Guided Adaptive Brachytherapy for Locally Advanced Cervical Cancer—A Single Institution Retrospective Study

por Faye, Mame Daro, Petruccelli Araujo, Mariana, Wissing, Michel D., Alrabiah, Khalid, Gilbert, Lucy, Zeng, Xing, Souhami, Luis, Alfieri, Joanne
Publicado 2023

SARS-CoV-2 antibodies persist up to 12 months after natural infection in healthy employees working in non-medical contact-intensive professions

por Mioch, Dymphie, Vanbrabant, Leonard, Reimerink, Johan, Kuiper, Sandra, Lodder, Esther, van den Bijllaardt, Wouter, Kluytmans, Jan, Wissing, Michel D.
Publicado 2023

SARS-CoV-2 antibodies in employees working in non-medical contact-intensive professions in the Netherlands: Baseline data from the prospective COco-study

por Mioch, Dymphie, Kuiper, Sandra, van den Bijllaardt, Wouter, van Jaarsveld, Cornelia H.M., Kluytmans, Jan, Lodder, Esther, Wissing, Michel D.
Publicado 2021

Liquid biopsy‐based targeted gene screening highlights tumor cell subtypes in patients with advanced prostate cancer

por Derderian, Seta, Vesval, Quentin, Wissing, Michel D., Hamel, Lucie, Côté, Nathalie, Vanhuyse, Marie, Ferrario, Cristiano, Bladou, Franck, Aprikian, Armen, Chevalier, Simone
Publicado 2022

Small-molecule screening of PC3 prostate cancer cells identifies tilorone dihydrochloride to selectively inhibit cell growth based on cyclin-dependent kinase 5 expression

por WISSING, MICHEL D., DADON, TIKVA, KIM, EUNICE, PIONTEK, KLAUS B., SHIM, JOONG S., KAELBER, NADINE S., LIU, JUN O., KACHHAP, SUSHANT K., NELKIN, BARRY D.
Publicado 2014

Nuclear Eg5 (kinesin spindle protein) expression predicts docetaxel response and prostate cancer aggressiveness

por Wissing, Michel D., De Morrée, Ellen S., Dezentjé, Vincent O., Buijs, Jeroen T., De Krijger, Ronald R., Smit, Vincent T.H.B.M., Van Weerden, Wytske M., Gelderblom, Hans, van der Pluijm, Gabri
Publicado 2014

Downregulation of Homologous Recombination DNA Repair Genes by HDAC Inhibition in Prostate Cancer Is Mediated through the E2F1 Transcription Factor

por Kachhap, Sushant K., Rosmus, Nadine, Collis, Spencer J., Kortenhorst, Madeleine S. Q., Wissing, Michel D., Hedayati, Mohammad, Shabbeer, Shabana, Mendonca, Janet, Deangelis, Justin, Marchionni, Luigi, Lin, Jianqing, Höti, Naseruddin, Nortier, Johan W. R., DeWeese, Theodore L., Hammers, Hans, Carducci, Michael A.
Publicado 2010

Combining the pan-aurora kinase inhibitor AMG 900 with histone deacetylase inhibitors enhances antitumor activity in prostate cancer

por Paller, Channing J, Wissing, Michel D, Mendonca, Janet, Sharma, Anup, Kim, Eugene, Kim, Hea-Soo, Kortenhorst, Madeleine S Q, Gerber, Stephanie, Rosen, Marc, Shaikh, Faraz, Zahurak, Marianna L, Rudek, Michelle A, Hammers, Hans, Rudin, Charles M, Carducci, Michael A, Kachhap, Sushant K
Publicado 2014